Merck KGaA (OTCMKTS:MKKGY) Issues Earnings Results

Merck KGaA (OTCMKTS:MKKGY) issued its earnings results on Thursday. The company reported $0.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.27, Zacks reports. Merck KGaA had a return on equity of 9.78% and a net margin of 13.49%.The business had revenue of $6.17 billion during the quarter, compared to the consensus estimate of $6.08 billion.

Merck KGaA Price Performance

OTCMKTS:MKKGY traded down $0.63 during midday trading on Friday, hitting $27.56. 963,300 shares of the stock were exchanged, compared to its average volume of 146,126. The business has a 50-day moving average price of $26.34 and a two-hundred day moving average price of $26.23. The company has a current ratio of 1.24, a quick ratio of 0.78 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $17.81 billion, a price-to-earnings ratio of 11.58, a P/E/G ratio of 3.23 and a beta of 0.96. Merck KGaA has a one year low of $24.32 and a one year high of $31.80.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Zacks Research raised Merck KGaA to a “hold” rating in a report on Friday, August 8th. Barclays downgraded shares of Merck KGaA from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 19th. Two research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.